ArticleAging2023

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma.

Xiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.